Search research articles
Contact Us
Filters
Showing results (141-150 of 247) with videos related to
Page
of 25
Sort By:
Journal of Neuropathology and Experimental Neurology
|
May 1, 1996
Role of complement in the aetiology of Pick's disease?
S K Singhrao, J W Neal, P Gasque, et al.
Arthritis and Rheumatism
|
October 1, 2004
Deletion of the gene encoding CD59a in mice increases disease severity in a murine model of rheumatoid arthritis
A S Williams, M Mizuno, P J Richards, et al.
Journal of Immunological Methods
|
November 25, 1983
Immunoaffinity purification of human complement component C9 using monoclonal antibodies
B P Morgan, R A Daw, K Siddle, et al.
Biochemistry
|
August 5, 1997
Mapping the regions of the complement inhibitor CD59 responsible for its species selective activity
J Yu, S Dong, N K Rushmere, et al.
The Biochemical Journal
|
December 1, 1994
Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site
N K Rushmere, R A Harrison, C W van den Berg, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 26, 1999
Differential expression of individual complement regulators in the brain and choroid plexus
S K Singhrao, J W Neal, N K Rushmere, et al.
The American Journal of Pathology
|
September 12, 2000
Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis
S K Singhrao, J W Neal, N K Rushmere, et al.
Cytogenetics and Cell Genetics
|
August 18, 1999
Assignment of MCP encoding the porcine membrane cofactor protein (MCP/CD46) to the long arm of pig chromosome 9 with somatic cell hybrids
J M Pérez de la Lastra, N K Rushmere, M Yerle, et al.
Kidney International
|
July 1, 1994
Role of CD59 in experimental glomerulonephritis in rats
S Matsuo, H Nishikage, F Yoshida, et al.
The Biochemical Journal
|
May 1, 1995
Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor
A B Zaltzman, C W Van den Berg, V R Muzykantov, et al.
Page
of 25
Search research articles
Search
Showing results (141-150 of 247) with videos related to
Sort By:
Page
of 25
Journal of Neuropathology and Experimental Neurology
|
May 1, 1996
Role of complement in the aetiology of Pick's disease?
S K Singhrao, J W Neal, P Gasque, et al.
Arthritis and Rheumatism
|
October 1, 2004
Deletion of the gene encoding CD59a in mice increases disease severity in a murine model of rheumatoid arthritis
A S Williams, M Mizuno, P J Richards, et al.
Journal of Immunological Methods
|
November 25, 1983
Immunoaffinity purification of human complement component C9 using monoclonal antibodies
B P Morgan, R A Daw, K Siddle, et al.
Biochemistry
|
August 5, 1997
Mapping the regions of the complement inhibitor CD59 responsible for its species selective activity
J Yu, S Dong, N K Rushmere, et al.
The Biochemical Journal
|
December 1, 1994
Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site
N K Rushmere, R A Harrison, C W van den Berg, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 26, 1999
Differential expression of individual complement regulators in the brain and choroid plexus
S K Singhrao, J W Neal, N K Rushmere, et al.
The American Journal of Pathology
|
September 12, 2000
Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis
S K Singhrao, J W Neal, N K Rushmere, et al.
Cytogenetics and Cell Genetics
|
August 18, 1999
Assignment of MCP encoding the porcine membrane cofactor protein (MCP/CD46) to the long arm of pig chromosome 9 with somatic cell hybrids
J M Pérez de la Lastra, N K Rushmere, M Yerle, et al.
Kidney International
|
July 1, 1994
Role of CD59 in experimental glomerulonephritis in rats
S Matsuo, H Nishikage, F Yoshida, et al.
The Biochemical Journal
|
May 1, 1995
Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor
A B Zaltzman, C W Van den Berg, V R Muzykantov, et al.
Page
of 25